ADAR1 Capital Management, LLC
Q4 2024 13F Holdings
- Locationaustin, TX
- Num holdings
214
- Value ($000)
$500,371
- Date Filed02/13/2025
- Form type13F-HR
- CIK0001940272
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
ROIVANT SCIENCES LTD | SHS | G76279101 | $41.51M | 8 % | 3,508,694 | ||
PTGX PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | $39.38M | 8 % | 1,020,333 | ||
BOXX EA SERIES TRUST | ALPHA ARCH 1-3 | 02072L565 | $35.89M | 7 % | 325,450 | ||
ZLAB ZAI LAB LTD | ADR | 98887Q104 | $27.39M | 6 % | 1,045,837 | ||
IMVT IMMUNOVANT INC | COM | 45258J102 | $19.51M | 4 % | 787,478 | ||
CYTK CYTOKINETICS INC | COM NEW | 23282W605 | $19.48M | 4 % | 414,209 | ||
BBIO BRIDGEBIO PHARMA INC | COM | 10806X102 | $18.63M | 4 % | 678,857 | ||
IKT INHIBIKASE THERAPEUTICS INC | COM NEW | 45719W205 | $16.58M | 3 % | 5,103,005 | ||
KRE SPDR SER TR | BLOOMBERG 1-3 MO | 78468R663 | $12.05M | 2 % | 131,786 | ||
ABIVAX SA | SPONSORED ADS | 00370M103 | $11.08M | 2 % | 1,513,393 |
Rows Per Page
1 - 10 of 21410
- 10
- 50
- 100